期刊文献+

实验性重症肌无力大鼠模型的建立及巨噬细胞在发病机制中的作用探讨 被引量:1

The establishment of experimental autoimmune mysathenia gravis(EAMG) and study of the role of macrophage in the pathogenesis of EAMG
下载PDF
导出
摘要 目的探讨早期重症肌无力发病机理中巨噬细胞的作用及巨噬细胞相关的细胞因子和趋化因子的变化。方法用原位杂交探索在EAMG动物模型靶器官肌肉组织中细胞因子和趋化因子mRNA的表达。采用原位杂交和免疫细胞化学染色双染技术,检测在Lewis大鼠EAMG早期,巨噬细胞浸润和程序性细胞凋亡。结果在EAMG早期观察在7和12天的EAMG大鼠肌肉组织中可见TNF-α、IL-1β和IL-6mRNA的表达细胞瞬时爆发,其峰值分别是(8.7±2.2)、(13.1±1.2)和(6.9±2.4)cells/mm2。第15天TNF-αmRNA的表达细胞数量再一次上升,IFN-γ、IL-4、IL-10、TGF-β和溶细胞素的mRNA表达细胞非常低。这些细胞主要在EAMG的早期观察到,范围是1~4cells/mm2。结论(1)EAMG早期大量巨噬细胞浸润,程序性细胞凋亡是浸润的巨噬细胞消除的主要方式;(2)EAMG早期于肌肉组织中细胞因子低水平表达;没有发现C-C趋化因子。 Objective:To explore the function of macrophage and the change of cytokine and chemokine related to macrophage in the early experimental autoimmune myasthenia gravis (EAMG). Methods: In-situ hybridization was applied to explore cytokine and chemokine mRNA expression in sections of striated muscle. Combining in situ tailing and irmnanocytochemical staining was applied to detect the infiltrating macrophages and apoptotic macrophages in muscle tissue sections during early phase of EAMG in Lewis rats. Results: A transient burst of TNF-α, IL-1β and IL-6 mRNA expressing cells was detected during the early phase of EAMG, the peak values of which were ( 8. 7 ±2. 2), ( 13.1 ± 1.2) and (6. 9 ±2. 4) cells/mm2. TNF-α mRNA expressing cells elevated in the 15th day gain. During the early phase of EAMG. !evels of IFN-γ, IL-4, IL-10, cytolysin and TGF-β mRNA expressing cells were low, the range of which was 1-4 cells/mm^2. Conclusion:Apoptosis is the major cause for elimination of infiltrating macrophages during the early phase of EAMG. During the early phase of EAMG cytokine mRNA expressing cells are low. C-C chemokine mRNA expressing cells are not detected.
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2006年第11期1010-1013,共4页 Chinese Journal of Immunology
基金 "十五"国家科技攻关计划引导项目(No.2004BA754C)
关键词 实验性自身免疫性重症肌无力 趋化因子 细胞因子 巨噬细胞 凋亡 Experimental autoimmune myasthenia gravis Chemokine Cytokine Macrophages Apoptosis
  • 相关文献

参考文献9

  • 1Paas-Rozner M,Sela M,Mozes E.A dual altered peptide ligand down-regulates myasthenogenic T cell responses by up-regulating CD25-and CTLA-4-expressing CD4+T cells[J].Proc Natl Acad Sci USA,2003;100:6676-6681.
  • 2Ceremuga T E,Yao X L,McCabe J T.Etiology,mechanisms,and anesthesia implications of autoimmune myasthenia gravis[J].AANA J,2002;70:301-310.
  • 3Cross A K,Haddock G,Surr J et al.Differential expression of ADAMTS-1,-4,-5 and TIMP-3 in rat spinal cord at different stages of acute experimental autoimmune encephalomyelitis[J].J Autoimmun,2006;26:16-23.
  • 4Quinones M P,Ahuja S K,Jimenez F et al.Experimental arthritis in CC chemokine receptor 2-null mice closely mimics severe human rheumatoid arthritis[J].J Clin Invest,2004;113:856-866.
  • 5Christadoss P,Poussin M,Deng C.Animal models of myasthenia gravis[J].Clin Immunol,2000;94:75-87.
  • 6Lennon V A,Lindstrom J M,Seybold M E.Experimental autoimmune myasthenia:a model of myasthenia gravis in rats and guinea pigs[J].J Exp Med,1975;141:1365-1375.
  • 7Hoedemaekers A,Graus Y,Beijleveld L et al.Macrophage infiltration at the neuromuscular junction does not contribute to AChR loss and age-related resistance to EAMG[J].J Neuroimmunol,1997;75:147-155.
  • 8Shi F D,Zhang G X,Bai X F et al.Cellular mRNA expression of interferon-gamma(IFN-gamma),IL-4 and IL-10 relates to resistance to experimental autoimmune myasthenia gravis(EAMG) in young Lewis rats[J].Clin Exp Immunol,1997;108:523-528.
  • 9De Baets M,Stassen M,Losen M et al.Immunoregulation in experimental autoimmune myasthenia gravis-about T cells,antibodies,and endplates[J].Ann N Y Acad Sci,2003;998:308-317.

同被引文献11

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部